Antiepileptic drug-induced bone loss in young male patients who have seizures

Archives of Neurology

Volumn 59, Issue 5, 2002, Pages 781-786

  Andress, Dennis L ^a   Ozuna, Judy ^a   Tirschwell, David ^a   Grande, Lucinda ^a   Johnson, Meshell ^a   Jacobson, Arnold F ^a   Spain, William ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BONE ATROPHY; BONE DENSITY; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEIZURE; TREATMENT OUTCOME;

EID: 0036094249     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.5.781     Document Type: Article

References (27)

1. Osteomalacia with long-term anticonvulsant therapy in epilepsy
2. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults
3. The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium and parathyroid hormone
4. Osteomalacia accompanying chronic anticonvulsant therapy
5. Incidence of anticonvulsant osteomalacia and effect of vitamin D: Controlled therapeutical trial
6. Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment
7. 2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia
8. Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy, I: A survey of 288 patients
9. Bone status in nonambulant, epileptic, institutionalized youth: Improvement with vitamin D therapy
10. 2
11. Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy
12. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
13. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
14. Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur
15. Bone mineral mass in hip fracture patients
16. Hip fracture prediction in elderly men and women: Validation in the Rotterdam study
17. Fracture risk is increased in epilepsy
18. Proximal femur bone mineral levels in US adults
19. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo
20. Increases in bone density during treatment of men with idiopathic hypogadotropic hypogonadism
21. Androgen supplementation in eugonadal men with osteoporosis: Effects of six months' treatment on markers of bone formation and resorption
22. Sex hormone changes in male epileptics
23. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin
24. Serum hormones in male epileptic patients receiving anticonvulsant medication
25. Effects of long-term anti-epileptic therapy on the catabolism of testosterone
26. Phenytoin-induced elevation of serum estradiol and reproductive dysfunction in men with epilepsy
27. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism